We will be working with our members and external experts to identify the best fit for respiratory services in the three shifts - analogue to digital, hospital to community and sickness to prevention
Wishing our research colleagues a fantastic time at the @BTSrespiratory Winter Meeting today! 🫁
Together, we're striving for better respiratory outcomes and working to make the UK a global leader in lung research. Let's transform the future of lung health!
As #LungCancerAwarenessMonth draws to an end, I reflect on the link between silicosis and lung cancer. We are seeing an increase in #silicosis cases caused by working with #engineeredstone. Action needs to be taken to prevent unnecessary silica-induced lung cancer diagnoses.
NICE recommends a new take at home injection treatment for adults with a rare inherited nerve disease.
Find out more about eplontersen for treating hereditary transthyretin-related amyloidosis: https://t.co/91yOg6ek0G
Launched today 🚀 First steps to implement the new BTS/NICE/SIGN asthma guideline.
This is a high-level summary of what the new guideline means for you as a primary healthcare professional and what steps you need to take to implement it effectively.
▶️ https://t.co/VXpaiYslAg
Lung conditions are the leading cause of emergency hospital admissions and levels of basic care are on a downward trend - powerful words from @swoolnough at #BTSWinter2024
New UK-wide asthma guideline launched
Developed collaboratively by BTS, NICE, and SIGN, it revolutionises asthma diagnosis and treatment by recommending combination treatments instead of ‘reliever-only’ inhalers for newly diagnosed cases.
Learn more: https://t.co/q2MGY2ChHd
📢New UK-wide asthma guideline launched
Developed by @BTSrespiratory, NICE and @signguidelines it revolutionises asthma diagnosis and treatment by recommending combination treatments instead of ‘reliever-only’ inhalers for newly diagnosed cases.
🔗https://t.co/pleWkUb1Dr
This month, #pulmonaryfibrosis was raised as a key issue in a parliamentary debate.
Thank you to @michellewelshMP for championing the work of APF and calling on the NHS to implement our new consensus care pathway for ILD services.
Find out more here:
https://t.co/cASsv8MkJY
Research tells us that SABA overuse is an indicator of poorly controlled asthma - so what conversations do we need to have for that to change?
PCRS members can tune in to this podcast for a break down of these challenging conversations 🎧 https://t.co/jW1TDAKzQC
As part of the Medical Care – driving change respiratory focus for October, we collaborated with @BTSrespiratory.
We’ve included pieces from NRAP clinical lead @ProfWilks, sustainability lead @DrHClements and @NHSEngland’s Targeted Lung Health Check: https://t.co/DvCxsTedfU